v3.25.2
Summary of Significant Accounting Policies - Schedule of Computation of Basic and Diluted Net Loss Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Numerator:        
Net income (loss) $ 15,653 $ (24,003) $ 6,299 $ (70,578)
Less: Net income (loss) attributable to noncontrolling interests (14) 7 (254) (47)
Net income (loss) attributable to Alignment Healthcare, Inc. $ 15,667 $ (24,010) $ 6,553 $ (70,531)
Denominator:        
Total weighted-average common shares outstanding (in shares) 198,328,613 191,431,917 196,003,736 190,514,927
Less: Restricted shares of common stock (in shares) 0 (540,130) (23,167) (566,202)
Total weighted-average common shares outstanding, net of restricted shares of common stock - basic (in shares) 198,328,613 190,891,787 195,980,569 189,948,725
Dilutive effect of:        
Shares used to compute diluted income (loss) per common share (in shares) 209,519,629 190,891,787 201,576,078 189,948,725
Net income (loss) per share:        
Basic income (loss) per share (in dollars per share) $ 0.08 $ (0.13) $ 0.03 $ (0.37)
Diluted income (loss) per share (in dollars per share) $ 0.07 $ (0.13) $ 0.03 $ (0.37)
Stock options        
Dilutive effect of:        
Dilutive effect of common shares (in shares) 405,903 0 202,952 0
RSUs        
Dilutive effect of:        
Dilutive effect of common shares (in shares) 8,111,256 0 4,055,628 0
PSUs        
Dilutive effect of:        
Dilutive effect of common shares (in shares) 2,673,857 0 1,336,929 0